D-0415-2022 Class II Terminated

Recalled by Edge Pharma, LLC — Colchester, VT

FDA drug recall D-0415-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 3747 syringes.

Recall details

Product Type
Drugs
Report Date
Feb 2, 2022
Initiation Date
Dec 6, 2021
Termination Date
Jun 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3747 syringes

Product description

Phenylephrine HCl 0.5 mg/5mL, (0.1 mg/mL), 5 mL per syringe, Single Use Syringe for IV Injection, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT 05446, NDC 05446-1545-05

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

nationwide

Code information

09-2021-09@4 12/22/2021 & 10-2021-14@1 01/26/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0415-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0415-2022. Report a data issue: hello@regdatalab.com.